Impact of Practice-Level Telehealth on Quality Outcomes in Chronic Care

By João L. Carapinha

July 6, 2026

practice-level telehealth quality outcomes

Practice-level telehealth quality outcomes remained stable for access and preventable hospitalizations among Medicare beneficiaries with chronic conditions during the COVID-19 pandemic. High-adopting primary care practices preserved care continuity while delivering modestly lower performance on select disease-specific quality measures, highlighting the need for stronger support systems around virtual chronic disease management.

Continuity Improves, Select Quality Measures Slip

Practice-level telehealth quality outcomes showed an 8.3 percent relative increase in the Bice-Boxerman continuity index with no rise in preventable emergency department visits or ambulatory care–sensitive hospitalizations. However, beta-blocker prescribing for heart failure dropped by 4 percentage points and blood pressure control rates for hypertension fell by 10 points.

Investigators classified practices as high or low telehealth adopters based on the share of virtual visits from April 2020 to December 2021, then applied a difference-in-differences framework to Medicare claims linked with electronic health record data from three PCORI-funded networks. The approach attributed patients to their pre-pandemic practice, adjusted for demographics, rurality, socioeconomic factors, and clinical complexity, and confirmed parallel pre-pandemic trends.

Policy Signal for Post-2027 Telehealth Rules

These practice-level telehealth quality outcomes supply health economics and outcomes research teams with actionable evidence as Medicare’s telehealth flexibilities near their 2027 expiration. The findings argue for conditioning future coverage on integration with structured remote monitoring and chronic care protocols so that expanded access strengthens rather than erodes outcome performance.

Read the full study in npj Digital Medicine.

Reference url

Recent Posts

large language models
Large Language Models in Evidence-Based Medicine

By João L. Carapinha

July 3, 2026

Large language models deliver rapid synthesis of medical literature, but according to research on fast information and slow evidence, they cannot independently generate validated evidence for clinical decisions. These tools sit at a...
African Pharmacogenomic Integration
African Pharmacogenomic Integration Enhancing Essential Medicine Prescribing in Africa

By João L. Carapinha

July 3, 2026

African Pharmacogenomic Integration has become an urgent policy priority, with evidence showing that more than 10 percent of essential medicines across Africa require genetically guided prescribing to prevent harm and improve outcomes in diverse populations. Current dosage guidelines for HIV, ...
pharmaceutical manufacturing affordability
Pharmaceutical Manufacturing Affordability as a Key to South Africa’s Local Production Goals

By João L. Carapinha

July 3, 2026

Pharmaceutical manufacturing affordability remains the decisive factor in South Africa’s efforts to build domestic capacity for essential medicines and vaccines. Government, industry and research leaders who met at the TIPS Development Dialogue on 17 June made clear that economic barriers to acce...